Area of research
Cancer Research · Otorhinolaryngology
Research interest
Research interests include Head and Neck Cancer Studies, Cancer Genomics and Diagnostics, MicroRNA in disease regulation, and Cancer-related molecular mechanisms research.
EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer
The <scp>TBLR1</scp> / <scp>TBL1</scp> Co‐Factor Complex Acts as a Transcriptional Checkpoint in the Brown Adipose Tissue Response to Prolonged Cold Exposure
Adjuvant (chemo)radiotherapy for patients with head and neck cancer: can comorbidity risk scores predict outcome?
Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment
DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score
Simultaneous metabolite MALDI-MSI, whole exome and transcriptome analysis from formalin-fixed paraffin-embedded tissue sections
Biopsy-derived oral keratinocytes – A model to potentially test for oral mucosa radiation sensitivity
DeepClassPathway: Molecular pathway aware classification using explainable deep learning
Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer Patients
Analysis of clonogenic growth in vitro
Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma
Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond
Tumor <scp>DNA‐methylome</scp> derived epigenetic fingerprint identifies <scp>HPV</scp>‐negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy
Improved risk stratification in younger<i>IDH</i>wild-type glioblastoma patients by combining a 4-miRNA signature with<i>MGMT</i>promoter methylation status
Prospektive Validierung einer prognostischen 4-miRNA-Signatur bei Glioblastom-Patienten
Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis
A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection
Ionizing radiation biomarkers in epidemiological studies – An update
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma
OC-0441: Genomic amplification of FancA in HNSCC: mechanisms of radioresistance and clinical relevance
Novel Approach of MALDI Drug Imaging, Immunohistochemistry, and Digital Image Analysis for Drug Distribution Studies in Tissues